These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 30326904)

  • 1. An analysis of country adoption and implementation of the 2012 WHO recommendations for intermittent preventive treatment for pregnant women in sub-Saharan Africa.
    Henry M; Florey L; Youll S; Gutman JR
    Malar J; 2018 Oct; 17(1):364. PubMed ID: 30326904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coverage of intermittent preventive treatment and insecticide-treated nets for the control of malaria during pregnancy in sub-Saharan Africa: a synthesis and meta-analysis of national survey data, 2009-11.
    van Eijk AM; Hill J; Larsen DA; Webster J; Steketee RW; Eisele TP; ter Kuile FO
    Lancet Infect Dis; 2013 Dec; 13(12):1029-42. PubMed ID: 24054085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WHO antenatal care policy and prevention of malaria in pregnancy in sub-Saharan Africa.
    Olapeju B; Bride M; Gutman JR; Wolf K; Wabwire S; Atobrah D; Babanawo F; Akrofi OO; Atta-Obeng C; Soro BK; Touré F; Shekarau E; Hendrickson ZM
    Malar J; 2024 Jul; 23(1):218. PubMed ID: 39044194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016.
    Azizi SC
    BMC Public Health; 2020 Mar; 20(1):335. PubMed ID: 32178658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing adherence to the new intermittent preventive treatment of malaria in pregnancy policy in Keta District of the Volta region, Ghana.
    Vandy AO; Peprah NY; Jerela JY; Titiati P; Manu A; Akamah J; Maya ET; Torpey K
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):424. PubMed ID: 31747927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual, facility and policy level influences on national coverage estimates for intermittent preventive treatment of malaria in pregnancy in Tanzania.
    Marchant T; Nathan R; Jones C; Mponda H; Bruce J; Sedekia Y; Schellenberg J; Mshinda H; Hanson K
    Malar J; 2008 Dec; 7():260. PubMed ID: 19094198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The readiness of malaria services and uptake of intermittent preventive treatment in pregnancy in six sub-Saharan countries.
    Xu X; Liang D; Zhao J; Mpembeni R; Olenja J; Yam EL; Huang J
    J Glob Health; 2024 Jun; 14():04112. PubMed ID: 38939971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
    Peters PJ; Thigpen MC; Parise ME; Newman RD
    Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of community delivery of intermittent preventive treatment of malaria in pregnancy on its coverage in four sub-Saharan African countries (Democratic Republic of the Congo, Madagascar, Mozambique, and Nigeria): a quasi-experimental multicentre evaluation.
    González R; Manun'Ebo MF; Meremikwu M; Rabeza VR; Sacoor C; Figueroa-Romero A; Arikpo I; Macete E; Mbombo Ndombe D; Ramananjato R; LIach M; Pons-Duran C; Sanz S; Ramírez M; Cirera L; Maly C; Roman E; Pagnoni F; Menéndez C
    Lancet Glob Health; 2023 Apr; 11(4):e566-e574. PubMed ID: 36925177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
    Fernandes S; Sicuri E; Kayentao K; van Eijk AM; Hill J; Webster J; Were V; Akazili J; Madanitsa M; ter Kuile FO; Hanson K
    Lancet Glob Health; 2015 Mar; 3(3):e143-53. PubMed ID: 25701992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.
    Walker PG; Floyd J; Ter Kuile F; Cairns M
    PLoS Med; 2017 Feb; 14(2):e1002243. PubMed ID: 28245259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cluster randomized trial of delivery of intermittent preventive treatment of malaria in pregnancy at the community level in Malawi.
    Rubenstein BL; Chinkhumba J; Chilima E; Kwizombe C; Malpass A; Cash S; Wright K; Troell P; Nsona H; Kachale F; Ali D; Kaunda E; Lankhulani S; Kayange M; Mathanga DP; Munthali J; Gutman JR
    Malar J; 2022 Jun; 21(1):195. PubMed ID: 35729612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine-pyrimethamine five dose policy in Ghana.
    Owusu-Boateng I; Anto F
    Malar J; 2017 Aug; 16(1):323. PubMed ID: 28797296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coverage of intermittent preventive treatment of malaria in pregnancy in four sub-Saharan countries: findings from household surveys.
    Pons-Duran C; Llach M; Sacoor C; Sanz S; Macete E; Arikpo I; Ramírez M; Meremikwu M; Mbombo Ndombe D; Méndez S; Manun'Ebo MF; Ramananjato R; Rabeza VR; Tholandi M; Roman E; Pagnoni F; González R; Menéndez C
    Int J Epidemiol; 2021 May; 50(2):550-559. PubMed ID: 33349871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.
    Orish VN; Onyeabor OS; Boampong JN; Afoakwah R; Nwaefuna E; Acquah S; Sanyaolu AO; Iriemenam NC
    Afr Health Sci; 2015 Dec; 15(4):1087-96. PubMed ID: 26958008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antenatal care visit attendance, intermittent preventive treatment and bed net use during pregnancy in Gabon.
    Bouyou-Akotet MK; Mawili-Mboumba DP; Kombila M
    BMC Pregnancy Childbirth; 2013 Feb; 13():52. PubMed ID: 23442536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent screening and treatment with dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy: implementation feasibility in a routine healthcare system setting in western Kenya.
    Hill J; Ouma P; Oluoch S; Bruce J; Kariuki S; Desai M; Webster J
    Malar J; 2020 Nov; 19(1):433. PubMed ID: 33238999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the consistency of national-level policies and guidelines for malaria in pregnancy in five African countries.
    Gomez PP; Gutman J; Roman E; Dickerson A; Andre ZH; Youll S; Eckert E; Hamel MJ
    Malar J; 2014 Jun; 13():212. PubMed ID: 24888703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.
    Azizi SC; Chongwe G; Chipukuma H; Jacobs C; Zgambo J; Michelo C
    BMC Pregnancy Childbirth; 2018 Apr; 18(1):108. PubMed ID: 29678150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria-related ideational factors and other correlates associated with intermittent preventive treatment among pregnant women in Madagascar.
    Awantang GN; Babalola SO; Koenker H; Fox KA; Toso M; Lewicky N
    Malar J; 2018 Apr; 17(1):176. PubMed ID: 29695231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.